Success Stories: A Postdoctoral Research Scientist in the Field of Biotechnologies Secured NIW Approval with Our Cutting-edge Petition Packet

Client’s Testimonial:

“Thanks for the satisfactory service, I highly recommend this firm. Thank you so much.”

On March 28^th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biotechnologies (Approval Notice).

General Field: Biotechnologies

Position at the Time of Case Filing: Postdoctoral Research Scientist

Country of Origin: Nepal

State of Residence at the Time of Filing: Louisiana

Approval Notice Date: March 28^th, 2023

Processing Time: 4 months, 25 days

Case Summary:

Our client is an outstanding postdoctoral research scientist in the field of biotechnologies, holding an advanced degree professional by virtue of his Ph.D. in biological sciences, which he acquired from a well-known U.S. University. Back in 2022, our client hired our firm for his NIW (National Interest Waiver) petition. Our experienced attorneys and team members vigilantly reviewed his background information and designed a petition package most suitable to him.

We successfully claimed that he had employed his impressive research expertise to make several major contributions to the field of biotechnologies. His research field focused on identifying the molecular mechanisms of plant tolerance to extreme environments to design and engineer crops and plants with superior tolerance to those environments. Through the continued implementation and dissemination of his research, the benefits would impact all parts of the nation. In addition, his outstanding work is of great importance because it addresses significant challenges facing agriculture around the world today.

After a complete evaluation, we affirmed that we could help him secure the national interest waiver. Our team gathered all the relevant key points to be emphasized in his petition packet confirming his academic and professional attainments. Here are some of the following details:

His work had resulted in a multitude of papers published in top scientific journals with international recognition. He had published 7 peer-reviewed journal articles, which altogether amassed 90 citations, concluding that he has a major influence on other scholars in the field. Besides, he conducted 16 peer reviews for highly acclaimed journals to date. This indicates the significance and impact of his investigations and vast knowledge in this area of study.
Due to his research’s national importance, it has in fact been supported with funding from the National Science Foundation (NSF), the Department of Energy (DoE), and the U.S. Department of Agriculture (USDA). His receipt of funding from these high-level government organizations is a testament to the significance of his research to the nation at large.
We also submitted all the documents proving his outstanding research ability and strong letters of recommendation from the leading specialists in his field testifying that he was among the top researchers in his field. We submitted his petition with all the relevant evidence in November 2022, and it was approved in March 2023.

Successfully, we proved to the USCIS that our client should be allowed to continue his research in the U.S. as he offers invaluable contributions and on the whole, it would benefit the United States. Thus, USCIS only took 4 months to adjudicate his case wisely and granted the NIW approval. Our team at the North America Immigration Law Group thanks our client for his cordial cooperation throughout the process and for allowing us to be a part of this success story.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.